COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

RecruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

March 19, 2020

Primary Completion Date

March 19, 2026

Study Completion Date

March 19, 2026

Conditions
Coronavirus Infections
Interventions
OTHER

Observational Study

Not required

Trial Locations (13)

2012

RECRUITING

Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute, Milan

2132

RECRUITING

Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute, Milan

20132

RECRUITING

AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -, Milan

RECRUITING

Department of Internal Medicine - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute, Milan

RECRUITING

Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute, Milan

RECRUITING

Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Nephrology Unit - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute, Milan

RECRUITING

Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute, Milan

RECRUITING

Università Vita-Salute San Raffaele, Milan

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER